Gene therapy firm Kriya Therapeutics snags $270m Series C

Kriya Therapeutics, Inc., a gene therapy company, has raised $270 million in Series C financing.

16 May 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles